Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-07 Sale | 2023-09-11 1:52 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,163 | $40.8 | $88,249 | 26,614 (Direct) | View |
| 2023-09-05 Sale | 2023-09-06 5:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 6,000 | $37.96 | $227,760 | 51,281 (Direct) | View |
| 2023-09-01 Sale | 2023-09-06 5:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 970 | $37.15 | $36,032 | 23,777 (Direct) | View |
| 2023-06-30 Sale | 2023-06-30 2:34 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 585 | $46.76 | $27,355 | 8,985 (Direct) | View |
| 2023-06-19 Sale | 2023-06-21 6:17 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 305 | $48.2 | $14,701 | 57,281 (Direct) | View |
| 2023-06-08 Sale | 2023-06-09 2:31 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 1,485 | $51.65 | $76,700 | 16,680 (Direct) | View |
| 2023-05-18 Sale | 2023-05-19 1:54 pm | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 2,012 | $50 | $100,600 | 74,744 (Direct) | View |
| 2023-05-04 Sale | 2023-05-05 2:16 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 4,378 | $45 | $197,010 | 51,982 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 8:00 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 3,881 | $45.25 | $175,615 | 46,720 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:59 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,161 | $45.25 | $143,035 | 95,539 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:57 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 1,968 | $45.27 | $89,091 | 286,260 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:54 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 100 | $45.65 | $4,565 | 31,835 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:53 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 389 | $45.65 | $17,758 | 104,115 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:53 pm | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 3,755 | $45.26 | $169,951 | 115,560 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 3,664 | $45.25 | $165,796 | 96,744 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 2:28 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 639 | $43.4 | $27,733 | 15,558 (Direct) | View |
| 2022-12-30 Sale | 2023-01-03 4:45 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 19,582 | $45.57 | $892,352 | 2,824,385 (Indirect Direct) | View |
| 2022-12-21 Sale | 2022-12-22 1:24 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,031 | $43.96 | $89,283 | 16,197 (Direct) | View |
| 2022-10-14 Sale | 2022-10-17 6:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President | 1,629 | $40.16 | $65,421 | 66,695 (Direct) | View |
| 2022-10-12 Sale | 2022-10-14 12:58 pm | Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President | 3,484 | $38.22 | $133,158 | 68,324 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-07 Exercise | 2023-09-11 1:52 pm | N/A 2024-01-29 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,000 | $0 | 26,614 (Direct) | View |
| 2023-09-07 Exercise | 2023-09-11 1:52 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,000 | $21 | 26,614 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:33 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director | 10,970 | $0 | 19,390 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:32 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 10,970 | $0 | 34,165 (Direct) | View |
| 2023-06-07 Disposition | 2023-06-09 2:32 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 3,300 | $51.82 | 34,165 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:31 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 10,970 | $0 | 16,680 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:30 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 10,970 | $0 | 21,965 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:30 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director | 10,970 | $0 | 28,715 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:29 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 10,970 | $0 | 26,840 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 2:28 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director | 10,970 | $0 | 28,715 (Direct) | View |
| 2023-05-09 Exercise | 2023-05-10 8:09 pm | N/A 2024-01-29 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $0 | 35,747 (Direct) | View |
| 2023-05-09 Exercise | 2023-05-10 8:09 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $21 | 35,747 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 6:18 pm | N/A 2033-05-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 13,020 | $0 | 38,874 (Direct) | View |
Ownership | 2023-05-02 6:14 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 0 | $0 | 74,844 (Direct) | View |
| 2023-04-16 Tax Withholding | 2023-04-18 4:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 14 | $38.2 | 27,520 (Direct) | View |
| 2023-04-16 Disposition | 2023-04-18 4:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 181 | $38.2 | 27,520 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:00 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 2,663 | $0 | 46,720 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:59 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 64,063 | $0 | 95,539 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:57 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 64,063 | $0 | 286,260 (Direct) | View |
| 2023-03-01 Disposition | 2023-03-03 7:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 3,394 | $45.65 | 286,260 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:54 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 17,710 | $0 | 31,835 (Direct) | View |
| 2023-03-01 Disposition | 2023-03-03 7:54 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 1,333 | $45.65 | 31,835 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:53 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 64,063 | $0 | 104,115 (Direct) | View |
| 2023-03-01 Disposition | 2023-03-03 7:53 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 10,599 | $45.65 | 104,115 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:53 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 64,063 | $0 | 115,560 (Direct) | View |
| 2023-03-01 Disposition | 2023-03-03 7:53 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 4,014 | $45.65 | 115,560 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 7:52 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 16,140 | $45.65 | 2,946,661 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:52 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 138,416 | $0 | 2,946,661 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:51 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 64,063 | $0 | 96,744 (Direct) | View |
| 2022-09-16 Option Award | 2022-09-19 9:39 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Dier Mardi CFO & Executive Vice President | 20,000 | $0 | 71,808 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-08 6:36 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 1,000 | $0 | 18,094 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-29 3:48 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 9,545 | $0 | 13,440 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:54 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director | 9,545 | $0 | 23,990 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:53 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director | 9,545 | $0 | 23,990 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:52 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 9,545 | $0 | 32,740 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:51 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director | 9,545 | $0 | 23,990 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:50 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director | 9,545 | $0 | 14,665 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 1:48 pm | N/A 2032-06-24 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 9,545 | $0 | 17,240 (Direct) | View |